Literature DB >> 22986449

Magnetic resonance spectroscopy study of the glutamatergic system in adolescent males with high-functioning autistic disorder: a pilot study at 4T.

Gagan Joshi1, Joseph Biederman, Janet Wozniak, Rachel L Goldin, Dave Crowley, Stephannie Furtak, Scott E Lukas, Atilla Gönenç.   

Abstract

The pilot study aimed at examining the neural glutamatergic activity in autism. Seven adolescent males (mean age: 14 ± 1.8; age range: 12-17 years) with intact intellectual capacity (mean IQ: 108 ± 14.26; IQ range: 85-127) suffering from autistic disorder and an equal number of age- and sex-matched healthy controls underwent a two-dimensional magnetic resonance spectroscopy scan at 4T. Results indicated significantly high glutamate (Glu) levels in the anterior cingulate cortex of autistic disorder versus control subjects (paired t test p = 0.01) and a trend for lower Glu in the right medial temporal lobe, which was not statistically different between the groups (paired t test p = 0.06). These preliminary findings support the glutamatergic dysregulation hypothesis in autism and need to be replicated in a larger sample.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22986449     DOI: 10.1007/s00406-012-0369-9

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  31 in total

1.  Variance components models for gene-environment interaction in quantitative trait locus linkage analysis.

Authors:  Shaun Purcell; Pak Sham
Journal:  Twin Res       Date:  2002-12

Review 2.  Neuropathology of infantile autism.

Authors:  T L Kemper; M Bauman
Journal:  J Neuropathol Exp Neurol       Date:  1998-07       Impact factor: 3.685

3.  Comparison of spectral fitting methods for overlapping J-coupled metabolite resonances.

Authors:  A Gonenc; V Govind; S Sheriff; A A Maudsley
Journal:  Magn Reson Med       Date:  2010-09       Impact factor: 4.668

4.  Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices.

Authors:  S Hossein Fatemi; Amy R Halt; Joel M Stary; Reena Kanodia; S Charles Schulz; George R Realmuto
Journal:  Biol Psychiatry       Date:  2002-10-15       Impact factor: 13.382

5.  High levels of cerebrospinal fluid glutamate in Rett syndrome.

Authors:  R Lappalainen; R S Riikonen
Journal:  Pediatr Neurol       Date:  1996-10       Impact factor: 3.372

Review 6.  The amygdala and related structures in the pathophysiology of autism.

Authors:  Thayne L Sweeten; David J Posey; Anantha Shekhar; Christopher J McDougle
Journal:  Pharmacol Biochem Behav       Date:  2002-03       Impact factor: 3.533

7.  Proton MR spectroscopy of the hippocampus at 3 T in patients with unipolar major depressive disorder: correlates and predictors of treatment response.

Authors:  Wolfgang Block; Frank Träber; Olrik von Widdern; Martin Metten; Hans Schild; Wolfgang Maier; Astrid Zobel; Frank Jessen
Journal:  Int J Neuropsychopharmacol       Date:  2008-10-10       Impact factor: 5.176

8.  Glutamine and glutamate levels in children and adolescents with bipolar disorder: a 4.0-T proton magnetic resonance spectroscopy study of the anterior cingulate cortex.

Authors:  Constance M Moore; Jean A Frazier; Carol A Glod; Janis L Breeze; Megan Dieterich; Chelsea T Finn; Blaise deB Frederick; Perry F Renshaw
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2007-04       Impact factor: 8.829

9.  In vivo 1H-magnetic resonance spectroscopy study of amygdala-hippocampal and parietal regions in autism.

Authors:  Lisa A Page; Eileen Daly; Nicole Schmitz; Andrew Simmons; Fiona Toal; Quinton Deeley; Fiona Ambery; Grainne M McAlonan; Kieran C Murphy; Declan G M Murphy
Journal:  Am J Psychiatry       Date:  2006-12       Impact factor: 18.112

10.  Six-month treatment with atypical antipsychotic drugs decreased frontal-lobe levels of glutamate plus glutamine in early-stage first-episode schizophrenia.

Authors:  Naoki Goto; Reiji Yoshimura; Shingo Kakeda; Joji Nishimura; Junji Moriya; Kenji Hayashi; Asuka Katsuki; Hikaru Hori; Wakako Umene-Nakano; Atsuko Ikenouchi-Sugita; Yukunori Korogi; Jun Nakamura
Journal:  Neuropsychiatr Dis Treat       Date:  2012-04-03       Impact factor: 2.570

View more
  33 in total

1.  The glutamate system as a therapeutic target and impact of genes on suicidality.

Authors:  Andrea Schmitt; Peter Falkai
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-08       Impact factor: 5.270

2.  Parsing the Heterogeneity of Brain Metabolic Disturbances in Autism Spectrum Disorder.

Authors:  Joseph O'Neill; Ravi Bansal; Suzanne Goh; Martina Rodie; Siddhant Sawardekar; Bradley S Peterson
Journal:  Biol Psychiatry       Date:  2019-06-21       Impact factor: 13.382

Review 3.  Searching for Cross-Diagnostic Convergence: Neural Mechanisms Governing Excitation and Inhibition Balance in Schizophrenia and Autism Spectrum Disorders.

Authors:  Jennifer H Foss-Feig; Brendan D Adkinson; Jie Lisa Ji; Genevieve Yang; Vinod H Srihari; James C McPartland; John H Krystal; John D Murray; Alan Anticevic
Journal:  Biol Psychiatry       Date:  2017-03-14       Impact factor: 13.382

4.  Medial Frontal Lobe Neurochemistry in Autism Spectrum Disorder is Marked by Reduced N-Acetylaspartate and Unchanged Gamma-Aminobutyric Acid and Glutamate + Glutamine Levels.

Authors:  Andreia Carvalho Pereira; Inês R Violante; Susana Mouga; Guiomar Oliveira; Miguel Castelo-Branco
Journal:  J Autism Dev Disord       Date:  2018-05

Review 5.  The role of glutamate and its receptors in autism and the use of glutamate receptor antagonists in treatment.

Authors:  Donald C Rojas
Journal:  J Neural Transm (Vienna)       Date:  2014-04-22       Impact factor: 3.575

6.  Glutamate-based magnetic resonance spectroscopy in neuroleptic malignant syndrome.

Authors:  Atri Chatterjee
Journal:  Ann Indian Acad Neurol       Date:  2014-01       Impact factor: 1.383

Review 7.  Revisiting the excitation/inhibition imbalance hypothesis of ASD through a clinical lens.

Authors:  Russell G Port; Lindsay M Oberman; Timothy Pl Roberts
Journal:  Br J Radiol       Date:  2019-06-11       Impact factor: 3.039

Review 8.  Developing Medications Targeting Glutamatergic Dysfunction in Autism: Progress to Date.

Authors:  Lawrence K Fung; Antonio Y Hardan
Journal:  CNS Drugs       Date:  2015-06       Impact factor: 5.749

9.  Relationship among Glutamine, γ-Aminobutyric Acid, and Social Cognition in Autism Spectrum Disorders.

Authors:  David M Cochran; Elif M Sikoglu; Steven M Hodge; Richard A E Edden; Ann Foley; David N Kennedy; Constance M Moore; Jean A Frazier
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-04-28       Impact factor: 2.576

Review 10.  Dysfunction of sensory oscillations in Autism Spectrum Disorder.

Authors:  David M Simon; Mark T Wallace
Journal:  Neurosci Biobehav Rev       Date:  2016-07-19       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.